z-logo
Premium
In vitro and in vivo antitumor effect of 2‐methoxyestradiol on human melanoma
Author(s) -
Dobos Judit,
Tímár József,
Bocsi József,
Burián Zsuzsanna,
Nagy Katalin,
Barna Gábor,
Peták István,
Ladányi Andrea
Publication year - 2004
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.20473
Subject(s) - 2 methoxyestradiol , melanoma , in vivo , apoptosis , cancer research , cell growth , in vitro , endogeny , mechanism of action , cell cycle checkpoint , biology , metabolite , estrogen , cell culture , pharmacology , cell cycle , endocrinology , biochemistry , genetics , microbiology and biotechnology
2‐methoxyestradiol (2ME 2 ) is an endogenous metabolite of estradiol with estrogen‐receptor‐independent antitumor and antiangiogenic activity. We examined the effects of 2ME 2 on the cellular proliferation of 8 human melanoma cell lines. We show that 2ME 2 inhibited cell proliferation by inducing apoptosis and an arrest in the G 2 /M phase, and the mechanism of action involved microtubules, mitochondrial damage and caspase activation. In male SCID mice, 2ME 2 was effective in reducing primary tumor weight and the number of liver metastases after intrasplenic injection of human melanoma cells. In the metastases, we found a significantly higher rate of apoptotic cells after 2ME 2 treatment. These findings on the antitumor effect of 2ME 2 in cell culture as well as in an animal model may have implications for designing alternative treatment options for patients with advanced malignant melanoma. © 2004 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom